Clinical Trial Update: Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating bevacizumab in combination with immune checkpoint inhibitors and hypofractionated stereotactic radiotherapy for symptom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma Brain Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Melanoma and Skin Cancer Trials Limited | Conditions: Melanoma Brain Metastases | Phase 1, Phase 2 | Status: RECRUITING